Literature DB >> 7117353

Pharmacokinetics of theophylline in patients following short-term intravenous infusion.

V W Steinijans, R Eicke, J Ahrens.   

Abstract

Serum theophylline concentrations after intravenous administration of a new short-term infusion (Euphyllin Kurzzeitinfusion) were measured in 50 out-patients with chronic obstructive airways disease (COAD). An intravenous infusion of theophylline ethylenediamine 480 mg (corresponding to approximately 350 mg anhydrous theophylline) in 50 ml isotonic solution was given in 20 min. Blood samples were taken beforehand and 25 to 30 min and 1, 3 and 6 h after starting the infusion. 86% of the patients had a one-hour serum level in he therapeutic range of 8.20 mg/l, and 2 h later, this was true of 64% of the patients. The short-term infusion was well tolerated, even in cases with unknown high pre-infusion serum levels. Pertinent pharmacokinetic parameters were determined, such as total body clearance, apparent volume of distribution, and half-life of elimination. Geometric mean an 95%-confidence limits, derived from the log-normal distribution of these parameters, were: Cl = 0.044 (0.018-0.190) l/h/kg ideal body weight, Vd = 0.451 (0.258-0.789) l/kg ideal body weight, and t 1/2(el) = 7.1 (2.6-19.1) h.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7117353     DOI: 10.1007/bf00542546

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Kinetics of intravenous theophylline.

Authors:  F A Chrzanowski; P J Niebergall; R L Mayock; J M Taubin; E T Sugita
Journal:  Clin Pharmacol Ther       Date:  1977-08       Impact factor: 6.875

Review 2.  Use of statistical methods in evaluation of in vivo performance of dosage forms.

Authors:  W J Westlake
Journal:  J Pharm Sci       Date:  1973-10       Impact factor: 3.534

3.  Bioavailability--a problem in equivalence.

Authors:  C M Metzler
Journal:  Biometrics       Date:  1974-06       Impact factor: 2.571

4.  Pharmacokinetics of intravenous theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  [Influence of aminophylline on the ventilation-perfusion ratio in obstructive ventilation disorders].

Authors:  H Fabel; R Wettengel
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1969-09

6.  Treating asthma in the elderly.

Authors:  A C Ghory; R Patterson
Journal:  Geriatrics       Date:  1980-08

7.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

Authors:  W J Jusko; M J Gardner; A Mangione; J J Schentag; J R Koup; J W Vance
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

8.  Effect of theophylline on mucociliary clearance in man.

Authors:  H Matthys; D Köhler
Journal:  Eur J Respir Dis Suppl       Date:  1980

9.  Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline.

Authors:  T H Rossing; C H Fanta; D H Goldstein; J R Snapper; E R McFadden
Journal:  Am Rev Respir Dis       Date:  1980-09

10.  Aminophylline improves diaphragmatic contractility.

Authors:  M Aubier; A De Troyer; M Sampson; P T Macklem; C Roussos
Journal:  N Engl J Med       Date:  1981-07-30       Impact factor: 91.245

View more
  4 in total

Review 1.  Review of methods and criteria for the evaluation of bioequivalence studies.

Authors:  G Pabst; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals.

Authors:  V W Steinijans; E Diletti
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  A non-parametric confidence interval method.

Authors:  A Racine-Poon; A P Grieve
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.